A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150

Clinical trial NCT01625390 · COMPLETED

Trial details

NCT number: NCT01625390
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hemophilia A, Hemophilia B

Start date: 2012-06-01
Primary completion: 2014-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.